The mRNA expression of the EMT markers significantly decreased following treatment with Tiplaxtinin in a concentration-dependent manner (Figs. 5E and 5F), indicating that the inhibition of SERPINE1 sufficiently suppressed the expression of EMT markers in GC. The gene discussed is SERPINE1; the disease is gastric cancer.